Prospective audit of the introduction of insulin glargine (lantus) into clinical practice in type 1 diabetic patients.
Gallen
Ian W
IW
Carter
Celia
C
D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000592:standards / Q000627:therapeutic use*; D007328:Insulin / Q000031:analogs & derivatives* / Q000592:standards / Q000627:therapeutic use*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D008485:Medical Audit
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting